Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience

机译：在韩国使用丙型肝炎病毒的肝移植受者中使用直接抗病毒药：两中心经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeThe proportion of liver recipients with HCV is gradually increasing in Korea. Limited data are available regarding the efficacy of direct antiviral agents (DAAs) in liver transplant recipients in Asia. We aimed to assess the efficacy and safety of DAAs in HCV-infected liver recipients in Korea.

机译：目的在韩国，HCV肝接受者的比例正在逐渐增加。关于直接抗病毒药物（DAA）在亚洲肝移植受者中的功效的可用数据有限。我们旨在评估DAA在韩国被HCV感染的肝脏接受者的疗效和安全性。

著录项

期刊名称 Annals of Surgical Treatment and Research
作者
Jong Man Kim; Kwang-Woong Lee; Dong-Hyun Sinn; Gyu-Seong Choi; Nam-Joon Yi; Choon Hyuck David Kwon; Kyung-Suk Suh; Jae-Won Joh;
展开▼
作者单位

展开▼
年(卷),期 2018(95),3
年度 2018
页码 147–151
总页数 5
原文格式 PDF
正文语种
中图分类外科学;
关键词
Safety Antiviral agents Liver transplantation Treatment outcome;

机译：安全性;抗病毒药物;肝移植;治疗结果;

相似文献

外文文献
中文文献
专利

1. Prophylaxis Among Hepatitis B Core Antibody-positive Deceased-donor Liver Transplant Recipients: Hepatitis B Immunoglobulin Plus Oral Antiviral Agents Versus Antiviral Agents Alone: A Single-center Experience [J] . Mohammad U. Malik, Enver Ucbilek, Panagiotis Trilianos, Experimental and clinical transplantation . 2017,第2期

机译：乙型肝炎核心抗体阳性的已故供者肝移植受者的预防：乙型肝炎免疫球蛋白加口服抗病毒药与单独抗病毒药：单中心经验
2. Prophylaxis Among Hepatitis B Core Antibody-positive Deceased-donor Liver Transplant Recipients: Hepatitis B Immunoglobulin Plus Oral Antiviral Agents Versus Antiviral Agents Alone: A Single-center Experience [J] . Mohammad U. Malik, Enver Ucbilek, Panagiotis Trilianos, Experimental and clinical transplantation . 2017,第2期

机译：乙型肝炎核心抗体阳性的已故供者肝移植受者的预防：乙型肝炎免疫球蛋白加口服抗病毒药与单独抗病毒药：单中心经验
3. Direct‐acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta‐analysis [J] . Liu Jiaye, Ma Buyun, Cao Wanlu, Transplant infectious disease: an official journal of the Transplantation Society . 2019,第2期

机译：具有复发基因型1丙型肝炎病毒感染的直接作用抗病毒试剂1丙型肝炎病毒感染：系统审查和荟萃分析
4. Genome-wide prediction and analysis of siRNA as potential antiviral agent against Hepatitis-C virus [C] . Divya Khanna, Vikas Kaushik, Atul Kumar Upadhyay International Conference on Bioinformatics and Systems Biology . 2018

机译：siRNA作为丙型肝炎病毒潜在抗病毒药物的全基因组预测和分析
5. Analyzing the Impact of the CMS Guidance on Assuring Access to Hepatitis C Virus (HCV) Drugs on Utilization of Direct-Acting Antiviral (DAA) Agents [D] . Ferrell, Kelli Walker. 2017

机译：分析CMS指南对确保获得丙型肝炎病毒（HCV）药物对直接作用抗病毒（DAA）药物利用的影响
6. Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection [O] . Keliang Chen, Pei Lu, Rijin Song, -1

机译：直接作用抗病毒药对慢性丙型肝炎病毒感染肾移植受者的疗效和安全性
7. Successful Treatment of Hepatitis C Virus Genotype 4 in Renal Transplant Recipients With Direct-Acting Antiviral Agents [O] . N. R. Hussein, Z. S. M. Saleem 2016

机译：用直接作用抗病毒剂的肾移植受者的成功治疗丙型肝炎病毒基因型4
8. Guidance for Industry Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Agents for Treatment [R] . 2010

机译：工业慢性丙型肝炎病毒感染指南：开发直接作用的抗病毒药物进行治疗

Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅